Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213017473> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W4213017473 endingPage "204512532110723" @default.
- W4213017473 startingPage "204512532110723" @default.
- W4213017473 abstract "The use of continuing antipsychotic medication is an established evidence-based strategy for preventing relapse in people with schizophrenia, but medication adherence is known to be suboptimal. Covert non-adherence can be eliminated by the use of long-acting injectable (LAI) formulations. We sought to (1) raise awareness among clinicians of the potential benefits of LAI antipsychotic formulations, (2) increase use of these formulations for the treatment of schizophrenia in routine clinical practice and thereby (3) reduce the number of relapses requiring hospitalisation in patients with schizophrenia under our care.Educational initiatives, promotion of reflective practice and patient-specific reminders were used to prompt increased use of LAI antipsychotic medication for patients with schizophrenia. Data relating to the use of these medications and the number of acute admissions for schizophrenia spectrum disorders (F20-29, ICD-10) over time were extracted from existing clinical information systems.Over the 3-year time frame of our local initiative, the use of LAI antipsychotic preparations increased by 11%, the number of acute admissions for schizophrenia/schizoaffective disorder (F20 and F25) decreased by 26% and the number of acute bed days occupied by patients with these diagnoses decreased by 8%. The number of admissions for other psychosis diagnoses (F21-24 and F28-29) did not show the same pattern of improvement.In our health care organisation, raising clinicians' awareness of the evidence base relating to the potentially favourable benefit-risk balance for LAI antipsychotic medication compared with oral formulations resulted in more use of the former. There were accompanying reductions in acute admissions and occupied bed days for patients with schizophrenia." @default.
- W4213017473 created "2022-02-24" @default.
- W4213017473 creator A5010726672 @default.
- W4213017473 creator A5078724624 @default.
- W4213017473 creator A5079852310 @default.
- W4213017473 date "2022-01-01" @default.
- W4213017473 modified "2023-09-26" @default.
- W4213017473 title "Can the use of long-acting injectable antipsychotic preparations be increased in routine clinical practice and the benefits realised?" @default.
- W4213017473 cites W1980278232 @default.
- W4213017473 cites W1996088043 @default.
- W4213017473 cites W2008702861 @default.
- W4213017473 cites W2011675347 @default.
- W4213017473 cites W2022692147 @default.
- W4213017473 cites W2037252107 @default.
- W4213017473 cites W2069612613 @default.
- W4213017473 cites W2074863161 @default.
- W4213017473 cites W2088866491 @default.
- W4213017473 cites W2099226437 @default.
- W4213017473 cites W2276191468 @default.
- W4213017473 cites W2326546984 @default.
- W4213017473 cites W2517254183 @default.
- W4213017473 cites W2623053349 @default.
- W4213017473 cites W2805061379 @default.
- W4213017473 cites W2806469814 @default.
- W4213017473 cites W2914101162 @default.
- W4213017473 cites W2957311488 @default.
- W4213017473 cites W3009122577 @default.
- W4213017473 cites W3043420940 @default.
- W4213017473 cites W3079510283 @default.
- W4213017473 cites W3154038235 @default.
- W4213017473 cites W3161940807 @default.
- W4213017473 cites W4206140259 @default.
- W4213017473 cites W4302304702 @default.
- W4213017473 doi "https://doi.org/10.1177/20451253211072347" @default.
- W4213017473 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35186261" @default.
- W4213017473 hasPublicationYear "2022" @default.
- W4213017473 type Work @default.
- W4213017473 citedByCount "4" @default.
- W4213017473 countsByYear W42130174732022 @default.
- W4213017473 countsByYear W42130174732023 @default.
- W4213017473 crossrefType "journal-article" @default.
- W4213017473 hasAuthorship W4213017473A5010726672 @default.
- W4213017473 hasAuthorship W4213017473A5078724624 @default.
- W4213017473 hasAuthorship W4213017473A5079852310 @default.
- W4213017473 hasBestOaLocation W42130174731 @default.
- W4213017473 hasConcept C118552586 @default.
- W4213017473 hasConcept C177713679 @default.
- W4213017473 hasConcept C2776412080 @default.
- W4213017473 hasConcept C2779727114 @default.
- W4213017473 hasConcept C2780057945 @default.
- W4213017473 hasConcept C2780325297 @default.
- W4213017473 hasConcept C2780494398 @default.
- W4213017473 hasConcept C71924100 @default.
- W4213017473 hasConceptScore W4213017473C118552586 @default.
- W4213017473 hasConceptScore W4213017473C177713679 @default.
- W4213017473 hasConceptScore W4213017473C2776412080 @default.
- W4213017473 hasConceptScore W4213017473C2779727114 @default.
- W4213017473 hasConceptScore W4213017473C2780057945 @default.
- W4213017473 hasConceptScore W4213017473C2780325297 @default.
- W4213017473 hasConceptScore W4213017473C2780494398 @default.
- W4213017473 hasConceptScore W4213017473C71924100 @default.
- W4213017473 hasLocation W42130174731 @default.
- W4213017473 hasLocation W42130174732 @default.
- W4213017473 hasLocation W42130174733 @default.
- W4213017473 hasLocation W42130174734 @default.
- W4213017473 hasOpenAccess W4213017473 @default.
- W4213017473 hasPrimaryLocation W42130174731 @default.
- W4213017473 hasRelatedWork W127140023 @default.
- W4213017473 hasRelatedWork W1983945019 @default.
- W4213017473 hasRelatedWork W2010001242 @default.
- W4213017473 hasRelatedWork W2021517845 @default.
- W4213017473 hasRelatedWork W2034989789 @default.
- W4213017473 hasRelatedWork W2089873036 @default.
- W4213017473 hasRelatedWork W2091458407 @default.
- W4213017473 hasRelatedWork W2097768453 @default.
- W4213017473 hasRelatedWork W2118787204 @default.
- W4213017473 hasRelatedWork W4363648554 @default.
- W4213017473 hasVolume "12" @default.
- W4213017473 isParatext "false" @default.
- W4213017473 isRetracted "false" @default.
- W4213017473 workType "article" @default.